Salix Pharmaceuticals

Salix Pharmaceuticals Overview

Founded 1989
Founded
Status Acquired/​Merged
Employees 1,000
Employees
Latest Deal Type M&A (Cancelled)
Latest Deal Amount $10B
Latest Deal Amount

Salix Pharmaceuticals General Information

Description

Provider of specialty pharmaceuticals. The company is focused on acquiring, developing and commercializing prescription drugs used in the treatment of gastrointestinal (GI) disorders

Contact Information

Website
Formerly Known As
Salix Holdings
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 400 Somerset Corporate Boulevard
  • Bridgewater, NJ 08807
  • United States
+1 (866) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Salix Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 01-Dec-2016 $10B 0000 Cancelled Profitable
7. Merger/Acquisition 01-Apr-2015 000.00 00000 000.00 Completed Profitable
6. Merger/Acquisition 11-Mar-2015 000.00 000.00 Cancelled Profitable
5. Debt - General 26-Nov-2013 00000 00000 Completed Profitable
4. Secondary Transaction - Open Market 10-Sep-2009 000.00 Completed Profitable
3. Secondary Transaction - Open Market 31-Dec-2003 000.00 Completed Profitable
2. PIPE 20-Nov-2000 $14.1M $28.3M Completed Profitable
1. IPO 16-Oct-1997 $15.2M $14.2M 000.00 Completed Profitable

Salix Pharmaceuticals Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Upsher-Smith Laboratories Corporate Backed or Acquired Maple Grove, MN 000000&0
0000000 0000000 Formerly PE-Backed Philadelphia, PA 0000 00000 000000000 00000
0000000000 Private Debt Financed Aachen, Germany 0000 00000 000000000 00000
000000000000 Corporate Backed or Acquired Staines-Upon-Thames, United Kingdom 0000 00.00 000000000000 00.00
000 Formerly PE-Backed Brussels, Belgium 0000 00000 000000 - 000 00000

Salix Pharmaceuticals Executive Team (12)

Name Title Board Seat Contact Info
Mark McKenna President & Chief Executive Officer
Jeffrey Gray Manager, Digital Marketing
Jordan Zwick Business Analyst (Business Development/Market Valuation)

9 Former Executives

Salix Pharmaceuticals Board Members (6)

To view Salix Pharmaceuticals‘s full board member team, request access »
Name Representing Role Since
John Chappell Self Board Member 000 0000
Thomas D'Alonzo JD Self Chairman & Acting Chief Executive Officer 000 0000

4 Former Board Members

Salix Pharmaceuticals Former Investors (2)

To view Salix Pharmaceuticals‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EW Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
Oxford Bioscience Partners Venture Capital Minority 000 0000 000000 0

Salix Pharmaceuticals Acquisitions (3)

To view Salix Pharmaceuticals‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 03-Jan-2014 000000000000000000 00.00 Pharmaceuticals 0000000 00000
000000 00000000000 20-Dec-2011 000000000000000000 00000 Pharmaceuticals
Inkine Pharmaceuticals 23-Jun-2005 Merger/Acquisition 00000 Pharmaceuticals 0000000 00000

Ready to get started?

Request a free trial